Loading company details...
Beta
Latest Form 4 (Sep 3, 2025): Gavin Wood (Chief Financial Officer): Sale of 96,000 shares, $950.40.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2025 | Gavin Wood, Chief Financial Officer | Sale | 96,000 | $950.40 |
| Aug 29, 2025 | William C. Bertrand Jr., Chief Operating Officer | Sale | 207,000 | $2.1K |
| Aug 19, 2025 | Ali Behbahani | Sale | 4,828,206 | $53.1K |
| Jul 30, 2025 | EcoR1 Capital, LLC | Sale | 33,931,740 | $3.82M |
| Feb 20, 2025 | William C. Bertrand Jr., Chief Operating Officer | Grant/Award | 1,612,032 | n/a |
| Feb 20, 2025 | Joanna Elizabeth Brewer, Chief Scientific Officer | Grant/Award | 1,612,032 | n/a |
| Feb 20, 2025 | John Lunger, Chief Patient Supply Officer | Grant/Award | 1,612,032 | n/a |
| Feb 20, 2025 | Cintia Piccina, Chief Commercial Officer | Grant/Award | 1,612,032 | n/a |
| Feb 20, 2025 | Elliot Norry, Chief Medical Officer | Grant/Award | 1,612,032 | n/a |
| Feb 20, 2025 | Adrian Rawcliffe, Chief Executive Officer | Grant/Award | 5,143,248 | n/a |